Venlafaxine Hydrochloride
- Product NDC
- 21695-961
- 11-digit product format
- 216950961
- Labeler code
- 21695
- Product ID
- 21695-961_5fab494d-cda2-4307-af04-0ce5fce1b2f9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Rebel Distributors Corp
- Application
- NDA020699
- Marketing category
- NDA
- Marketing start
- 2011-06-10
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 21695-961-30 | Venlafaxine Hydrochloride | 30 in 1 BOTTLE, PLASTIC | CAPSULE, EXTENDED RELEASE | 30 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| ETHYLCELLULOSE (100 MPA.S) | INACTIVE INGREDIENT | 47MLB0F1MV | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21695-961 | VENLAFAXINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [REBEL DISTRIBUTORS CORP] | 2 | Legacy NDC, 1 package rows | 20120223_2bb09fc1-1c0a-4586-9af9-5aed8d4322db.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 21695-961-30 | 21695096130 | 30 in 1 BOTTLE, PLASTIC | Historical |